V9 Anti-Human CD19 (Tafasitamab)
Product Specifications
Expression System
CHO
Reactivity
Human
Target
CD19
Purification
IEC
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Buffer
ABDB-1002 or PBS, pH 7.4, Contains no stabilizers or preservatives.
Storage Conditions
The product need to be stored at the original stock concentration at 4°C.Avoid freeze / thaw cycle.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives
Sterility
0.2 μM filtered
Isotype
Human IgG1 (S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M) -Kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470460-500 1x 500 µL
CD44 Standard (156-3C11), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400177-100 1x 100 µL
CD50 (ICAM-3) (101-1D2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470276-100 1x 100 µL
TAG-72 / CA72.4 (B72.3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680669-100 1x 100 µL
P27 / KIP1 (SX53G8), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details